(Q72613118)

English

Antagonists of bombesin/gastrin-releasing peptides as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer

scientific article published on 01 December 1993

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8242552%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

Antagonists of bombesin/gastrin-releasing peptides as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8242552%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

prostate cancer

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8242552%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

author name string

J Pinski

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8242552%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

G Halmos

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8242552%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

K Szepeshazi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8242552%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

language of work or name

0 references

publication date

1 December 1993

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8242552%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8242552%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

72

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8242552%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8242552%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

3263-3270

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8242552%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

0 references

The effects of gonadotrophin releasing hormone analogues in prostate cancer are mediated through specific tumour receptors

0 references

Combination of long-acting microcapsules of the D-tryptophan-6 analog of luteinizing hormone-releasing hormone with chemotherapy: investigation in the rat prostate cancer model

0 references

Production of epidermal growth factor and transforming growth factor-alpha by the androgen-responsive LNCaP human prostate cancer cell line

0 references

Leuprolide versus diethylstilbestrol for metastatic prostate cancer

0 references

Role of transforming growth factor-alpha in human prostate cancer cell growth

0 references

[D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro

0 references

Zoladex: a sustained-release, monthly luteinizing hormone-releasing hormone analogue for the treatment of advanced prostate cancer

0 references

Clinical study of leuprolide depot formulation in the treatment of advanced prostate cancer. The Leuprolide Study Group

0 references

Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone

0 references

Inhibition of growth of PC-82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC-3095 or combination of agonist [D-Trp6]-luteinizing hormone-releasing hormone and somatostatin analog RC-160

0 references

Effect of microcapsules of luteinizing hormone-releasing hormone antagonist SB-75 and somatostatin analog RC-160 on endocrine status and tumor growth in the Dunning R-3327H rat prostate cancer model

0 references

Androgen, estrogen and progesterone receptors of the R3327H Copenhagen rat prostatic tumor

0 references

Present status of agonistic and antagonistic analogs of LH-RH in the treatment of advanced prostate cancer

0 references

Growth inhibition of estrogen-dependent and estrogen-independent MXT mammary cancers in mice by the bombesin and gastrin-releasing peptide antagonist RC-3095

0 references

Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75.

0 references

Treatment of advanced prostate cancer

0 references

Prostatic cancer: aetiology and endocrinology

0 references

Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer

0 references

Analogues of luteinizing hormone-releasing hormone containing cytotoxic groups

0 references

Secretion of epidermal growth factor and related polypeptides by the DU 145 human prostate cancer cell line

0 references

Randomised controlled study of orchidectomy vs long-acting D-Trp-6-LHRH microcapsules in advanced prostatic carcinoma

0 references

Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

0 references

Bombesin stimulates growth of human prostatic cancer cells in vitro

0 references

Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia

0 references

LHRH analogue as a depot preparation (Zoladex) in the treatment of advanced carcinoma of the prostate followed by orchiectomy as a second line therapy--a phase II study

0 references

Early events elicited by bombesin and structurally related peptides in quiescent Swiss 3T3 cells. I. Activation of protein kinase C and inhibition of epidermal growth factor binding

0 references

The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancer

0 references

Identifiers

10.1002/1097-0142(19931201)72:11<3263::AID-CNCR2820721122>3.0.CO;2-V

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8242552%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8242552%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q72613118&oldid=1826303485"